Global Oncology Ablation Device 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR122402729

Publication Date:

December 6, 2024

Pages:

108

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Oncology Ablation Device market size was valued at USD 1389.1 million in 2023 and is forecast to a readjusted size of USD 2570 million by 2030 with a CAGR of 9.2% during review period.
Tumor Ablation is a general term for destroying cancer cells. Interventional ablation is a targeted, image-guided therapy for liver, kidney and lung cancers that uses the direct application of extreme heat (radiofrequency and microwave) or cold (cryoablation) to destroy tumor cells. It is most appropriate for small kidney and liver cancers that cannot be removed surgically. In fact, radiofrequency and cryoablation of small kidney cancers have been shown to be just as effective as major surgery.
Oncology Ablation Device market was driven by minimally invasive alternative to traditional surgical treatment of brain, liver, prostate, colorectal, kidney, breast, pancreatic and lung cancers.
The report includes an overview of the development of the Oncology Ablation Device industry chain, the market status of Liver Cancer (Radiofrequency Ablation, Microwave Ablation), Lung Cancer (Radiofrequency Ablation, Microwave Ablation), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oncology Ablation Device.
Regionally, the report analyzes the Oncology Ablation Device markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oncology Ablation Device market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oncology Ablation Device market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oncology Ablation Device industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Radiofrequency Ablation, Microwave Ablation).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oncology Ablation Device market.
Regional Analysis: The report involves examining the Oncology Ablation Device market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oncology Ablation Device market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oncology Ablation Device:
Company Analysis: Report covers individual Oncology Ablation Device players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oncology Ablation Device This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Liver Cancer, Lung Cancer).
Technology Analysis: Report covers specific technologies relevant to Oncology Ablation Device. It assesses the current state, advancements, and potential future developments in Oncology Ablation Device areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oncology Ablation Device market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Oncology Ablation Device market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Other
麻豆原创 segment by Application
Liver Cancer
Lung Cancer
Kidney Cancer
Others
麻豆原创 segment by players, this report covers
Boston Scientific
Medtronic
Johnson & Johnson
Merit Medical
Varian Medical
AngioDynamics
HealthTronics
EDAP TMS
SonaCare Medical
Misonix
CAScination AG
Biomedical Srl
Chongqing Haifu Medical
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncology Ablation Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncology Ablation Device, with revenue, gross margin and global market share of Oncology Ablation Device from 2019 to 2024.
Chapter 3, the Oncology Ablation Device competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Oncology Ablation Device market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology Ablation Device.
Chapter 13, to describe Oncology Ablation Device research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope of Oncology Ablation Device
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Oncology Ablation Device by Type
1.3.1 Overview: Global Oncology Ablation Device 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Oncology Ablation Device Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Radiofrequency Ablation
1.3.4 Microwave Ablation
1.3.5 Cryoablation
1.3.6 Other
1.4 Global Oncology Ablation Device 麻豆原创 by Application
1.4.1 Overview: Global Oncology Ablation Device 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Liver Cancer
1.4.3 Lung Cancer
1.4.4 Kidney Cancer
1.4.5 Others
1.5 Global Oncology Ablation Device 麻豆原创 Size & Forecast
1.6 Global Oncology Ablation Device 麻豆原创 Size and Forecast by Region
1.6.1 Global Oncology Ablation Device 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Oncology Ablation Device 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Oncology Ablation Device 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Oncology Ablation Device 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Oncology Ablation Device 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Oncology Ablation Device 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Oncology Ablation Device 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Boston Scientific
2.1.1 Boston Scientific Details
2.1.2 Boston Scientific Major Business
2.1.3 Boston Scientific Oncology Ablation Device Product and Solutions
2.1.4 Boston Scientific Oncology Ablation Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Boston Scientific Recent Developments and Future Plans
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Oncology Ablation Device Product and Solutions
2.2.4 Medtronic Oncology Ablation Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Medtronic Recent Developments and Future Plans
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Oncology Ablation Device Product and Solutions
2.3.4 Johnson & Johnson Oncology Ablation Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Johnson & Johnson Recent Developments and Future Plans
2.4 Merit Medical
2.4.1 Merit Medical Details
2.4.2 Merit Medical Major Business
2.4.3 Merit Medical Oncology Ablation Device Product and Solutions
2.4.4 Merit Medical Oncology Ablation Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Merit Medical Recent Developments and Future Plans
2.5 Varian Medical
2.5.1 Varian Medical Details
2.5.2 Varian Medical Major Business
2.5.3 Varian Medical Oncology Ablation Device Product and Solutions
2.5.4 Varian Medical Oncology Ablation Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Varian Medical Recent Developments and Future Plans
2.6 AngioDynamics
2.6.1 AngioDynamics Details
2.6.2 AngioDynamics Major Business
2.6.3 AngioDynamics Oncology Ablation Device Product and Solutions
2.6.4 AngioDynamics Oncology Ablation Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 AngioDynamics Recent Developments and Future Plans
2.7 HealthTronics
2.7.1 HealthTronics Details
2.7.2 HealthTronics Major Business
2.7.3 HealthTronics Oncology Ablation Device Product and Solutions
2.7.4 HealthTronics Oncology Ablation Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 HealthTronics Recent Developments and Future Plans
2.8 EDAP TMS
2.8.1 EDAP TMS Details
2.8.2 EDAP TMS Major Business
2.8.3 EDAP TMS Oncology Ablation Device Product and Solutions
2.8.4 EDAP TMS Oncology Ablation Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 EDAP TMS Recent Developments and Future Plans
2.9 SonaCare Medical
2.9.1 SonaCare Medical Details
2.9.2 SonaCare Medical Major Business
2.9.3 SonaCare Medical Oncology Ablation Device Product and Solutions
2.9.4 SonaCare Medical Oncology Ablation Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 SonaCare Medical Recent Developments and Future Plans
2.10 Misonix
2.10.1 Misonix Details
2.10.2 Misonix Major Business
2.10.3 Misonix Oncology Ablation Device Product and Solutions
2.10.4 Misonix Oncology Ablation Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Misonix Recent Developments and Future Plans
2.11 CAScination AG
2.11.1 CAScination AG Details
2.11.2 CAScination AG Major Business
2.11.3 CAScination AG Oncology Ablation Device Product and Solutions
2.11.4 CAScination AG Oncology Ablation Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 CAScination AG Recent Developments and Future Plans
2.12 Biomedical Srl
2.12.1 Biomedical Srl Details
2.12.2 Biomedical Srl Major Business
2.12.3 Biomedical Srl Oncology Ablation Device Product and Solutions
2.12.4 Biomedical Srl Oncology Ablation Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Biomedical Srl Recent Developments and Future Plans
2.13 Chongqing Haifu Medical
2.13.1 Chongqing Haifu Medical Details
2.13.2 Chongqing Haifu Medical Major Business
2.13.3 Chongqing Haifu Medical Oncology Ablation Device Product and Solutions
2.13.4 Chongqing Haifu Medical Oncology Ablation Device Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Chongqing Haifu Medical Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Oncology Ablation Device Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Oncology Ablation Device by Company Revenue
3.2.2 Top 3 Oncology Ablation Device Players 麻豆原创 Share in 2023
3.2.3 Top 6 Oncology Ablation Device Players 麻豆原创 Share in 2023
3.3 Oncology Ablation Device 麻豆原创: Overall Company Footprint Analysis
3.3.1 Oncology Ablation Device 麻豆原创: Region Footprint
3.3.2 Oncology Ablation Device 麻豆原创: Company Product Type Footprint
3.3.3 Oncology Ablation Device 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Oncology Ablation Device Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Oncology Ablation Device 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Oncology Ablation Device Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Oncology Ablation Device 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Oncology Ablation Device Consumption Value by Type (2019-2030)
6.2 North America Oncology Ablation Device Consumption Value by Application (2019-2030)
6.3 North America Oncology Ablation Device 麻豆原创 Size by Country
6.3.1 North America Oncology Ablation Device Consumption Value by Country (2019-2030)
6.3.2 United States Oncology Ablation Device 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Oncology Ablation Device 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Oncology Ablation Device 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Oncology Ablation Device Consumption Value by Type (2019-2030)
7.2 Europe Oncology Ablation Device Consumption Value by Application (2019-2030)
7.3 Europe Oncology Ablation Device 麻豆原创 Size by Country
7.3.1 Europe Oncology Ablation Device Consumption Value by Country (2019-2030)
7.3.2 Germany Oncology Ablation Device 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Oncology Ablation Device 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Oncology Ablation Device 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Oncology Ablation Device 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Oncology Ablation Device 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Oncology Ablation Device Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Oncology Ablation Device Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Oncology Ablation Device 麻豆原创 Size by Region
8.3.1 Asia-Pacific Oncology Ablation Device Consumption Value by Region (2019-2030)
8.3.2 China Oncology Ablation Device 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Oncology Ablation Device 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Oncology Ablation Device 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Oncology Ablation Device 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Oncology Ablation Device 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Oncology Ablation Device 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Oncology Ablation Device Consumption Value by Type (2019-2030)
9.2 South America Oncology Ablation Device Consumption Value by Application (2019-2030)
9.3 South America Oncology Ablation Device 麻豆原创 Size by Country
9.3.1 South America Oncology Ablation Device Consumption Value by Country (2019-2030)
9.3.2 Brazil Oncology Ablation Device 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Oncology Ablation Device 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Oncology Ablation Device Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Oncology Ablation Device Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Oncology Ablation Device 麻豆原创 Size by Country
10.3.1 Middle East & Africa Oncology Ablation Device Consumption Value by Country (2019-2030)
10.3.2 Turkey Oncology Ablation Device 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Oncology Ablation Device 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Oncology Ablation Device 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Oncology Ablation Device 麻豆原创 Drivers
11.2 Oncology Ablation Device 麻豆原创 Restraints
11.3 Oncology Ablation Device Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Oncology Ablation Device Industry Chain
12.2 Oncology Ablation Device Upstream Analysis
12.3 Oncology Ablation Device Midstream Analysis
12.4 Oncology Ablation Device Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Boston Scientific
Medtronic
Johnson & Johnson
Merit Medical
Varian Medical
AngioDynamics
HealthTronics
EDAP TMS
SonaCare Medical
Misonix
CAScination AG
Biomedical Srl
Chongqing Haifu Medical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.